S&P 500   3,851.85
DOW   31,188.38
QQQ   323.77
S&P 500   3,851.85
DOW   31,188.38
QQQ   323.77
S&P 500   3,851.85
DOW   31,188.38
QQQ   323.77
S&P 500   3,851.85
DOW   31,188.38
QQQ   323.77
Log in

Koninklijke DSM Stock Forecast, Price & News

+0.93 (+2.13 %)
(As of 01/20/2021 12:00 AM ET)
Today's Range
Now: $44.53
50-Day Range
MA: $42.64
52-Week Range
Now: $44.53
Volume42,587 shs
Average Volume24,749 shs
Market Capitalization$32.32 billion
P/E Ratio48.40
Dividend Yield0.87%
Koninklijke DSM N.V., a science-based company, engages in nutrition, health, and sustainable living businesses in the Netherlands, rest of Europe, North America, Latin America, China, India, Japan, rest of Asia, and internationally. It operates through Nutrition, Materials, and Innovation Center segments. The Nutrition segment offers animal nutrition and health products, including vitamins, enzymes, eubiotics, carotenoids, lipids, and minerals; human nutrition and health products comprising carotenoids, digestive enzymes, nutritional lipids, nutraceuticals, probiotic and prebiotics, and vitamins; and skin and sun care, hair care, and aroma ingredients. It also provides vitamin and lipid active pharmaceutical ingredients; omega-3 fatty acids; specialty enzymes, cultures, probiotics, bio-preservation, sugar reduction, and savory taste solutions; and specialty hydrocolloid solutions. The Materials segment provides thermoplastics used in automotive, electrical and electronics, building and construction, medical, food packaging, and consumer goods; coating resins and functional materials; Dyneema, a fiber solution for use in aviation, personal protection, marine, fishing, heavy lifting, and sports and lifestyle industries; and additives. The Innovation Center segment offers biomedical materials, and medical device and material manufacturing technologies in the areas of cardiovascular, dental, diabetes management, gynecology, neurology, ophthalmology, orthopedic, plastic and reconstructive surgery, soft tissue, and wound management. It also provides anti-reflective (AR) coatings for solar glass, retrofit AR and anti-soiling coatings, and conductive and PV backsheets; and yeast and enzymes for the conversion of starch, corn fiber, and biomass. The company has a partnership with Strait Access Technologies to develop trans-catheter replacement heart valves with polymeric leaflets. Koninklijke DSM N.V. was founded in 1902 and is headquartered in Heerlen, the Netherlands.
Koninklijke DSM logo


Overall MarketRank

1.17 out of 5 stars

Basic Materials Sector

257th out of 812 stocks

Chemicals & Allied Products Industry

21st out of 30 stocks

Analyst Opinion: 0.0Community Rank: 2.3Dividend Strength: 1.7Insider Behavior: 0.0Valuation: 1.9 5 -4 -3 -2 -1 -

Industry, Sector and Symbol

Industry Chemicals & allied products
Previous SymbolNASDAQ:RDSMY



Sales & Book Value

Annual Sales$10.09 billion
Cash Flow$2.28 per share
Book Value$12.09 per share


Net Income$848.96 million


Market Cap$32.32 billion
Next Earnings Date2/11/2021 (Estimated)
OptionableNot Optionable
+0.93 (+2.13 %)
(As of 01/20/2021 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive RDSMY News and Ratings via Email

Sign-up to receive the latest news and ratings for RDSMY and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles

Koninklijke DSM (OTCMKTS:RDSMY) Frequently Asked Questions

How has Koninklijke DSM's stock price been impacted by Coronavirus?

Koninklijke DSM's stock was trading at $27.56 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, RDSMY shares have increased by 61.6% and is now trading at $44.53.
View which stocks have been most impacted by COVID-19

Is Koninklijke DSM a buy right now?

8 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Koninklijke DSM in the last year. There are currently 2 sell ratings, 1 hold rating and 5 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" Koninklijke DSM stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in RDSMY, but not buy additional shares or sell existing shares.
View analyst ratings for Koninklijke DSM
or view MarketBeat's top 5 stock picks.

What stocks does MarketBeat like better than Koninklijke DSM?

Wall Street analysts have given Koninklijke DSM a "Hold" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Koninklijke DSM wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

When is Koninklijke DSM's next earnings date?

Koninklijke DSM is scheduled to release its next quarterly earnings announcement on Thursday, February 11th 2021.
View our earnings forecast for Koninklijke DSM

How were Koninklijke DSM's earnings last quarter?

Koninklijke DSM (OTCMKTS:RDSMY) released its earnings results on Tuesday, November, 3rd. The basic materials company reported $0.30 EPS for the quarter, missing analysts' consensus estimates of $0.31 by $0.01. The basic materials company earned $2.29 billion during the quarter. Koninklijke DSM had a return on equity of 9.81% and a net margin of 6.66%.
View Koninklijke DSM's earnings history

How often does Koninklijke DSM pay dividends? What is the dividend yield for Koninklijke DSM?

Koninklijke DSM announced a Semi-Annual dividend on Tuesday, August 4th. Investors of record on Friday, August 14th will be given a dividend of $0.188 per share on Friday, September 4th. The ex-dividend date is Thursday, August 13th.
View Koninklijke DSM's dividend history

Is Koninklijke DSM a good dividend stock?

Koninklijke DSM pays an annual dividend of $0.38 per share and currently has a dividend yield of 0.87%. The dividend payout ratio of Koninklijke DSM is 29.23%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, Koninklijke DSM will have a dividend payout ratio of 25.85% next year. This indicates that Koninklijke DSM will be able to sustain or increase its dividend.
View Koninklijke DSM's dividend history.

Are investors shorting Koninklijke DSM?

Koninklijke DSM saw a increase in short interest in the month of December. As of December 31st, there was short interest totaling 34,300 shares, an increase of 35.0% from the December 15th total of 25,400 shares. Based on an average daily trading volume, of 34,300 shares, the days-to-cover ratio is presently 1.0 days.
View Koninklijke DSM's Short Interest

Who are some of Koninklijke DSM's key competitors?

Who are Koninklijke DSM's key executives?

Koninklijke DSM's management team includes the following people:
  • Mr. Dimitri de Vreeze, Co-CEO & Member of the Managing Board (Age 54)
  • Ms. Geraldine Matchett, Co-CEO & Member of the Managing Board (Age 49)
  • Ms. Helen Mets, EVP-Materials, Interim Pres of Resins and Functional Materials & Member of Exec. Committee
  • Ms. Patricia Malarkey, Chief Innovation Officer & Member of Exec. Committee (Age 56)
  • Mr. Jos Op Heij, Sr. VP of Corp. Control & Accounting and Group Controller
  • Marcus Remmers, Chief Technology Officer
  • Mr. Dave Huizing, VP of Investor Relations
  • Mr. Cees Los, Director of Legal Affairs and Gen. Counsel (Age 65)
  • Ms. Cristina Monteiro, Exec. VP of People & Organization
  • Mr. Rob J. Atsma, Head of Energie Beheer Nederland (Age 75)

What is Koninklijke DSM's stock symbol?

Koninklijke DSM trades on the OTCMKTS under the ticker symbol "RDSMY."

How do I buy shares of Koninklijke DSM?

Shares of RDSMY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Koninklijke DSM's stock price today?

One share of RDSMY stock can currently be purchased for approximately $44.53.

How big of a company is Koninklijke DSM?

Koninklijke DSM has a market capitalization of $32.32 billion and generates $10.09 billion in revenue each year. The basic materials company earns $848.96 million in net income (profit) each year or $1.30 on an earnings per share basis. Koninklijke DSM employs 21,866 workers across the globe.

What is Koninklijke DSM's official website?

The official website for Koninklijke DSM is www.dsm.com.

How can I contact Koninklijke DSM?

Koninklijke DSM's mailing address is Het Overloon 1, Heerlrn P7, 6411 TE. The basic materials company can be reached via phone at 31-45-578-2864.

This page was last updated on 1/21/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.